title: Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia.
authors.forename: N
authors.initials: N
authors.lastname: Ito
authors.forename: Y
authors.initials: Y
authors.lastname: Shimizu
authors.forename: H
authors.initials: H
authors.lastname: Suzuki
authors.forename: T
authors.initials: T
authors.lastname: Saito
authors.forename: T
authors.initials: T
authors.lastname: Okamoto
authors.forename: M
authors.initials: M
authors.lastname: Hori
authors.forename: M
authors.initials: M
authors.lastname: Akahane
authors.forename: S
authors.initials: S
authors.lastname: Fukumoto
authors.forename: T
authors.initials: T
authors.lastname: Fujita
mesh_terms: D000328:Adult; D014408:Biomarkers, Tumor / Q000378:metabolism*; D001859:Bone Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000378:metabolism; D005260:Female; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000378:metabolism*; D006801:Humans; D017674:Hypophosphatemia / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D010018:Osteomalacia / Q000097:blood / Q000209:etiology*; D010257:Paraneoplastic Syndromes / Q000150:complications / Q000175:diagnosis*; D011446:Prospective Studies
chemical_list: D014408:Biomarkers, Tumor; C000717427:FGF23 protein, human; D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23